Capital Income Builder Class R-2 Shares (RIRBX)
The Capital Income Builder Class R-2 Shares mutual fund, with ticker symbol RIRBX, is a type of mutual fund that focuses on generating income for investors through a diverse portfolio of stocks and bonds. This fund aims to provide a steady stream of income while also seeking long-term capital growth. It is classified as a Class R-2 share, which typically has a lower expense ratio and requires a higher minimum investment compared to other share classes. This mutual fund is suitable for investors looking for a balanced approach to income and growth in their investment portfolio.
RIRBX Mutual Fund Chart & Stats
- Previous Close
- $84.47
- Sub-Category
- Asset Allocation
- Total Liabilities
- $2.85B
- Expense Ratio
- 1.35%
- Holding Count
- 2,766
- Brand
- Capital Income Builder
- Category
- Balanced
- Total Assets
- 133.31B
- Shares Outstanding
- N/A
- 52-Week Range
- $76.30 - $85.13
RIRBX Mutual Fund News
AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHCAPITAL GROUP CENTRAL CASH FUND | 4.22% |
| AVGOBroadcom Inc. | 4.02% |
| 2330TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 3.38% |
| PMPhilip Morris International | 2.94% |
| CCBFXCAPITAL GROUP CENTRAL CORPORATE BOND FUND | 2.04% |
| ABBVAbbvie | 1.93% |
| BATSBritish American Tobacco (UK) | 1.85% |
| RTXRtx Corporation | 1.57% |
| JPMJPMorgan Chase & Co. | 1.17% |
| AZNAstraZeneca plc | 1.10% |
| Total | 24.21% |
Recently Viewed
No data currently available














